Press Releases

Press Releases concerning clinical trial results are intended to inform interested parties of the advancements of laser technology in process, not to imply new indications for use. Erchonia supports only those indications for use, cleared by the FDA via 510(k).

Erchonia XLR8 Laser Granted FDA Clearance for Pain Treatment

Contact: Katie Cycan
Crier Communications
310-274-1072 x 207
katie@crierpr.com
 

Erchonia XLR8 Laser Granted FDA Clearance for Pain Treatment

Harvard Scientists Commend Erchonia for Excellence in Clinical Research for the Zerona Laser

Tuesday, August 6th 2013
 
In the latest volume of the medical journal, Lasers in Surgery and Medicine, three Harvard scientists concluded that Erchonia’s research for its Zerona low-level laser device has, "set the precedent on how aesthetic devices should be evaluated."
McKinney, TX (PRWEB) August 06, 2013

Erchonia Launches Zerona Model Search

Model Wins a Trip to Florida, $5,000 cash and Stars in Zerona’s 2012 Marketing Campaign